IM Cannabis (IMCC) Net Income (2020 - 2026)
IM Cannabis' (IMCC) quarterly Net Income came in at $1.8 million in Q1 2026, up 1375.03% year-on-year from $121960.4 in Q1 2025, and up 131.89% quarter-over-quarter from -$5.6 million in Q4 2025.
IM Cannabis (IMCC) Net Income (2020 - 2026) Analysis & Trends
IM Cannabis' Net Income history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- On a quarterly basis, Net Income rose 1375.03% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 90.86% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 2.0% from the prior year.
- Net Income rose to $1.8 million in Q1 2026 per IMCC's latest filing, from -$5.6 million in the prior quarter.
- Across five years, Net Income topped out at $98.2 million in Q3 2022 and bottomed at -$16.0 million in Q4 2024.
- The 5-year median for Net Income is $457562.1 (2024), against an average of $5.8 million.
- Across the five-year window, Net Income surged 2086.55% in 2022 and sank 518.21% in 2024, its largest moves.
- Year by year, Net Income stood at $24.6 million in 2022, then plunged by 110.49% to -$2.6 million in 2023, then sank by 518.21% to -$16.0 million in 2024, then surged by 64.71% to -$5.6 million in 2025, then surged by 131.89% to $1.8 million in 2026.
- Per Business Quant, the three latest IMCC Net Income figures stand at $1.8 million (Q1 2026), -$5.6 million (Q4 2025), and $2.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | -5.64 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | -112,587.15 |
| Mar 31, 2025 | 121,960.38 |
| Dec 31, 2024 | -15.98 Mn |
| Sep 30, 2024 | 793,163.79 |
| Jun 30, 2024 | 2.53 Mn |
| Mar 31, 2024 | 4.47 Mn |
| Dec 31, 2023 | -2.59 Mn |
| Sep 30, 2023 | -8.41 Mn |
| Mar 31, 2023 | -664,247.34 |
| Dec 31, 2022 | 24.64 Mn |
| Sep 30, 2022 | 98.25 Mn |
| Jun 30, 2022 | -11.98 Mn |
| Mar 31, 2022 | 2.89 Mn |
| Dec 31, 2021 | -19.47 Mn |
| Sep 30, 2021 | 4.49 Mn |
| Jun 30, 2021 | -4.14 Mn |
| Mar 31, 2021 | 3.73 Mn |